Dyskinesia, Drug-InducedKartagener SyndromeDyskinesiasBiliary DyskinesiaLevodopaCiliary Motility DisordersAntiparkinson AgentsAxonemal DyneinsChoreaBenserazideMovement DisordersParkinsonian DisordersCiliaAntipsychotic AgentsParkinson DiseaseOxidopamineSitus InversusParkinson Disease, SecondaryAkathisia, Drug-InducedAxonemeCorpus StriatumCarbidopaDopamine AgentsEpilepsy, Benign NeonatalDyneinsHistocompatibility Antigens Class IMPTP PoisoningHistocompatibility Antigens Class IIDopamine AgonistsSchizophreniaTranquilizing AgentsAdrenergic Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDystoniaBasal Ganglia DiseasesSerotonin 5-HT1 Receptor AgonistsMucociliary ClearanceMolecular Sequence DataPhenothiazinesGlobus PallidusHaloperidolBronchiectasisAmantadineDynorphinsSubthalamic NucleusNasal CavityBenzothiazolesReceptor, Serotonin, 5-HT1AReceptors, Dopamine D1ApomorphineCallithrixReceptors, Dopamine D3NeostriatumAmino Acid SequenceTropaeolaceaeReceptors, Dopamine8-Hydroxy-2-(di-n-propylamino)tetralinMutationTiapamil HydrochlorideStereoisomerismBase SequenceBasal GangliaSubstantia NigraMetoclopramideSerotonin AgentsAmishModels, MolecularDisease Models, AnimalNeurologic ExaminationMedial Forebrain BundleMotor ActivityDopamineNortropanesSphincter of OddiExomeSerotonin Receptor AgonistsPedigreeTime FactorsDose-Response Relationship, DrugTetrabenazineMolecular StructurePiribedilReceptors, Dopamine D2Dopamine and cAMP-Regulated Phosphoprotein 32Stereotyped BehaviorMagnetic Resonance SpectroscopyRats, Sprague-DawleyNucleic Acid ConformationHeterotaxy SyndromeAphakiaCommon Bile Duct DiseasesDeep Brain StimulationRisperidoneSperm TailG-Protein-Coupled Receptor KinasesPhenotypeSphincter of Oddi DysfunctionRespiratory SystemAntibodies, MonoclonalMacaca fascicularis